Multiple Myeloma Virtual Accredited Symposium Webinar | Integrating novel BCMA-directed therapies into clinical practice: Insights from real-world experience

The Multiple Myeloma Hub invites you to an exclusive virtual accredited symposium webinar on Wednesday, December 17, at 17.30–18.30 GMT, focusing on the latest advancements in BCMA-directed therapies for multiple myeloma (MM). In just 60 minutes, experts will share practical guidance, clinical evidence, and real-world experiences to help you integrate these innovative therapies into your practice.

This program has been submitted for accreditation for one hour of external CME credit.

During the session, you’ll gain a deeper understanding of BCMA-directed therapies, including how they work, the latest clinical trial and real-world data, and strategies for patient selection, sequencing, and retreatment. Experts will also discuss approaches to manage toxicities and optimize patient quality of life, providing actionable insights you can apply immediately in clinical care.

The webinar features insights from renowned specialists Dr Hermann Einsele (Chair), Marc-Andrea Bärtsch, Prof. Gordon Cook, and Dr María-Victoria Mateos, offering a comprehensive view of the current landscape and future directions in BCMA-targeted therapy. This is an ideal opportunity to hear firsthand experiences, explore practical treatment strategies, and stay at the forefront of multiple myeloma management. After the symposium, there will be a chance to join a virtual exhibitor room.

Don’t miss this chance to enhance your clinical practice and deliver better outcomes for your patients. Secure your place for this interactive session and gain expert insights into the evolving world of BCMA-directed therapies.

Register now!